XML 50 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Stock Option Activity (Details) - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Apr. 16, 2020
Apr. 15, 2020
Dec. 31, 2019
Jun. 06, 2019
Jun. 05, 2019
Options to purchase Common Stock              
Weighted-average assumptions              
Risk-free interest rate 0.44% 1.80%          
Dividend yield (as a percent) 0.00% 0.00%          
Expected volatility (as a percent) 104.70% 95.50%          
Expected term 5 years 10 months 24 days 5 years 10 months 24 days          
Number of Options              
Balance outstanding at the beginning of the period (in shares) 1,015,418            
Granted (in shares) 969,965            
Exercised (in shares) (3,333)            
Cancelled / Forfeited (in shares) (46,069)            
Expired (in shares) (15,275)            
Balance outstanding at the end of the period (in shares) 1,920,706            
Exercisable at the end of the period (in shares) 441,434            
Weighted Average Exercise Price Per Share              
Balance outstanding at the beginning of the period (in USD per share) $ 12.77            
Granted (in USD per share) 2.53            
Exercised (in USD per share) 2.05            
Canceled / Forfeited (in USD per share) 12.58            
Expired (in USD per share) 8.98            
Balance outstanding at the end of the period (in USD per share) 7.65            
Exercisable at the end of the period (in USD per share) $ 24.82            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures              
Options outstanding, intrinsic value $ 21,766,326       $ 0    
Vested and exercisable at the end of the period, intrinsic value $ 4,507,516            
2014 EIP              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures              
Authorized shares under the plan (in shares)     1,243,056 2,243,056   1,243,056 243,056
Number of remaining shares available for issuance (in shares) 258,497